GLP-1 coverage in Michigan

State coverage is the biggest single variable in what an American pays for a GLP-1, and it is the one that moves fastest. Michigan, on the record.

Michigan Medicaid covers GLP-1s for obesity — but has narrowed who qualifies.

Michigan is one of the states KFF lists as covering GLP-1s for obesity treatment. It has also restricted eligibility to patients with morbid obesity rather than those who are overweight or obese, a change expected to save the state an estimated $240 million. Everything below is sourced — we are not going to tell you what a Michigan clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.

Why the desk tracks this

Because it is the largest single price variable in the market and it moves without notice. Four states cut coverage inside a year, one cut and restored it during a budget stalemate, and two more have proposals filed. No telehealth company repriced that fast.

Why Michigan is different

Michigan is the clearest example in the country of the middle path states are taking: not eliminating coverage outright, but tightening the threshold until the budget works. That is a materially different situation from California or Pennsylvania, where the route closed entirely — and it means the question here is not whether coverage exists but whether you clear the bar.

Medicaid and GLP-1s in Michigan

Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where Michigan sits.

Paying cash in Michigan

Providers are licensed across all 50 states and charge the same here as anywhere, so there is no local price to hunt for — the cheapest verified all-in rates are Ozari Health at $86 for semaglutide and Trimi at $125 for tirzepatide. Full tables in the cheapest tirzepatide. If you buy compounded, check the pharmacy licence with the Michigan Board of Pharmacy,

Michigan: common questions

Does Michigan still cover Wegovy or Zepbound?

KFF lists Michigan among the states covering GLP-1s for obesity. The restriction is on who qualifies — the state narrowed eligibility to morbid obesity rather than overweight or obese — not on whether the drugs are covered at all.

What does the $240 million figure refer to?

It is the saving Michigan expects from restricting eligibility to morbidly obese patients. It is a useful number to hold onto because it shows what is driving these decisions nationally: budget, not clinical evidence.

Sources: KFF, “Medicaid Coverage of and Spending on GLP-1s”, 16 January 2026; CDC Adult Obesity Prevalence Maps, 2024 data, published 3 December 2025. Verified 2026-09-18. Coverage positions change mid-year — confirm yours with your plan. Not medical, legal or benefits advice.